Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Hologic Inc (HOLX)

Hologic Inc (HOLX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 12,556,872
  • Shares Outstanding, K 263,302
  • Annual Sales, $ 3,367 M
  • Annual Income, $ -203,600 K
  • 60-Month Beta 0.85
  • Price/Sales 3.80
  • Price/Cash Flow 11.56
  • Price/Book 5.76

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.62
  • Number of Estimates 8
  • High Estimate 0.65
  • Low Estimate 0.61
  • Prior Year 0.58
  • Growth Rate Est. (year over year) +6.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.96 +0.48%
on 02/28/20
55.25 -16.42%
on 02/04/20
-8.44 (-15.45%)
since 01/28/20
3-Month
45.96 +0.48%
on 02/28/20
55.25 -16.42%
on 02/04/20
-5.22 (-10.16%)
since 11/27/19
52-Week
42.61 +8.38%
on 04/22/19
55.25 -16.42%
on 02/04/20
-0.97 (-2.06%)
since 02/28/19

Most Recent Stories

More News
Five Companies Transforming the Future of Breast Cancer Care

When caught early enough, the five-year survival rates are 99%, says the American Cancer Society. However, early detection is essential, which is why experts strongly advised screening. After all, "Where...

IZO.CN : 0.205 (+2.50%)
IZOZF : 0.1600 (+10.04%)
HOLX : 46.50 (-2.50%)
SYK : 187.51 (-3.77%)
NEO : 26.89 (-2.25%)
CLVS : 7.22 (+5.56%)
Alydia Health Strengthens Leadership Team with Appointment of Dr. Edward Evantash as Chief Medical Officer

Alydia Health, a clinical-stage medical device company dedicated to making childbirth safer for all mothers, today announced the appointment of Dr. Edward Evantash as Chief Medical Officer. Dr. Evantash...

HOLX : 46.50 (-2.50%)
Gynecological Surgical Devices Market 2019 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2025

The report provides rational insights along with historical and forecast data to said in better understanding of the Global Gynecological Surgical Devices Market. The report provides a comprehensive analysis...

BSX : 36.85 (-2.82%)
HOLX : 46.50 (-2.50%)
MDT : 97.98 (-2.97%)
Medical Imaging Market 2020 Growth Factors, Technological Advancement and Trends by Manufacturers: RamSoft, Inc., InHealth Group, Radiology Reports online, Siemens Healthineers, Sonic Healthcare, RadNet

Global Medical Imaging Market is forecasted to grow at 10.4% with factors such as increasing prevalence of chronic diseases and development of innovative medical imaging contrast agents.

AIQ : 17.00 (-2.47%)
HOLX : 46.50 (-2.50%)
RDNT : 20.04 (-4.80%)
SHMZF : 25.5000 (+4.08%)
SKHCF : 20.4970 (-2.21%)
Big Advances in Breast Cancer Screening Creating Sizable Opportunities

While we should all be diligent in cancer detection and treatment in every month of the year, February is well known as National Cancer Prevention Month. It's an annual campaign to increase awareness of...

IZO.CN : 0.205 (+2.50%)
IZOZF : 0.1600 (+10.04%)
HOLX : 46.50 (-2.50%)
ATNX : 11.79 (-1.01%)
SGEN : 107.30 (-0.93%)
CLVS : 7.22 (+5.56%)
Hologic to Webcast Presentations at Upcoming Investor Conferences

Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at these upcoming investor conferences:

JPM : 116.16 (-4.29%)
HOLX : 46.50 (-2.50%)
2020-2025 Human Papillomavirus (HPV) Testing Industry Report - Roche, Qiagen, Hologic and Abbott are Dominating the Competition

The "Human Papillomavirus (HPV) Testing Market - Global Outlook and Forecast 2020 - 2025" report has been added to ResearchAndMarkets.com's offering.

HOLX : 46.50 (-2.50%)
The Top Companies to Watch in the Fight Against Breast Cancer in 2020

Breast cancer is the most devastating, common cancer among women. On average, one out of every eight women in the U.S. along will develop this cancer in her lifetime. Worse, every two minutes a woman...

NVDQ : 11.75 (unch)
IZO.CN : 0.205 (+2.50%)
IZOZF : 0.1600 (+10.04%)
HOLX : 46.50 (-2.50%)
SYK : 187.51 (-3.77%)
NDRA : 1.11 (-5.93%)
BSX : 36.85 (-2.82%)
Hologic Expands Panther Portfolio With New Product Offerings

Hologic's (HOLX) latest offerings are set to improve flexibility and efficiency of laboratories.

HOLX : 46.50 (-2.50%)
RMD : 155.27 (-4.58%)
HRC : 95.32 (-3.93%)
LMAT : 28.48 (-4.24%)
Hologic Inc Falls 1.35% on Heavy Volume: Watch For Potential Rebound

Hologic Inc (NASDAQ:HOLX) traded in a range yesterday that spanned from a low of $53.84 to a high of $54.17. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $53.89...

HOLX : 46.50 (-2.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Average short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade HOLX with:

Business Summary

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research...

See More

Key Turning Points

2nd Resistance Point 50.12
1st Resistance Point 48.90
Last Price 46.50
1st Support Level 46.87
2nd Support Level 46.06

See More

52-Week High 55.25
Fibonacci 61.8% 50.42
Fibonacci 50% 48.93
Fibonacci 38.2% 47.44
Last Price 46.50
52-Week Low 42.61

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar